Stocks Telegraph

LAB Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:LAB

Standard BioTools Inc.

$1.88
-0.0076-0.40%
Open: 11:30 AM
72.26
B-ESG ScoreESG Rating
Loading...

Stock Price Today

Standard BioTools Inc. (LAB) stock declined over -0.40%, trading at $1.88 on NASDAQ, down from the previous close of $1.89. The stock opened at $1.87, fluctuating between $1.86 and $1.90 in the recent session.

Stock Snapshot

1.89
Prev. Close
1.87
Open
698.66M
Market Cap
371.15M
Number of Shares
1.8601
Day Low
1.895
Day High
-2.14
P/E Ratio
96.76%
Free Float in %
-0.88
EPS (TTM)
2.05
Book Value
-0.58
Cash Flow per Share
102.58K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Oct 14, 20241.851.901.801.89911.91K
Oct 11, 20241.771.901.771.891.42M
Oct 10, 20241.741.781.691.781.35M
Oct 09, 20241.791.801.731.781.11M
Oct 08, 20241.811.871.781.80873.01K
Oct 07, 20241.831.871.811.821.52M
Oct 04, 20241.861.881.821.85594.9K
Oct 03, 20241.831.851.801.81558.61K
Oct 02, 20241.861.881.791.861.24M
Oct 01, 20241.911.921.831.871.16M
Sep 30, 20241.911.951.861.93927.81K
Sep 27, 20241.931.951.901.92885.42K
Sep 26, 20241.881.911.821.901.58M
Sep 25, 20241.971.991.821.831.49M
Sep 24, 20241.891.981.871.971.56M
Sep 23, 20242.002.001.861.871.31M
Sep 20, 20242.082.081.992.014.83M
Sep 19, 20242.122.152.062.111.16M
Sep 18, 20241.952.151.922.031.32M
Sep 17, 20242.082.121.972.011.35M

Contact Details

South San Francisco, CA 94080

United States

Website: https://www.fluidigm.comContact: 650 266 6000

About Company

Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Standard BioTools Inc. has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Company Information

Employees534
Beta1.582
Sales or Revenue$106.34M
5Y Sales Change%-0.528%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Diagnostics & Research

Frequently Asked Questions

What is the current Standard BioTools Inc. (LAB) stock price?

Standard BioTools Inc. (NASDAQ: LAB) stock price is $1.88 in the last trading session. During the trading session, LAB stock reached the peak price of $1.90 while $1.86 was the lowest point it dropped to. The percentage change in LAB stock occurred in the recent session was -0.4% while the dollar amount for the price change in LAB stock was -$0.01.

LAB's industry and sector of operation?

The NASDAQ listed LAB is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Standard BioTools Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of LAB?

Mr. Jeremy Steven Davis
Chief Commercial Officer
Dr. Stephen R. Quake D.phil., Ph.D.
Co-Founder & Chairman of Advisory Board
Mr. Andrew Quong Ph.D.
Chief Science Officer
Mark Spearman
Senior Director of Corporation Communications
Mr. Jeffrey G. Black
Senior Vice President & Chief Financial Officer
Dr. David A. King Ph.D.
Senior Vice President of Global R&D
Dr. Michael Egholm Ph.D.
Pres, Chief Executive Officer & Director
Mr. Hanjoon Kim
Chief Operating Officer
Ms. Agnieszka M. Gallagher J.D.
Senior Vice President & Chief Legal Officer
Steve Kulisch
Senior Vice President, GM & Head of Strategic Marketing
Mr. Vikram Jog
Chief Financial Officer
Mr. Stephen Christopher Linthwaite
Advisor
Ms. Angela Peters
Chief HR Officer
Mr. Rafael Aguirre-Sacasa
Acting Gen. Counsel
Ms. Mona Abou-Sayed
Senior Vice President of SBS
Mr. Peter DeNardo
Senior Director of Investor Relations & Corporation Communications

How LAB did perform over past 52-week?

LAB's closing price is 56.2% higher than its 52-week low of $1.21 where as its distance from 52-week high of $3.04 is -37.83%.

How many employees does LAB have?

Number of LAB employees currently stands at 534.

Link for LAB official website?

Official Website of LAB is: https://www.fluidigm.com

How do I contact LAB?

LAB could be contacted at phone 650 266 6000 and can also be accessed through its website. LAB operates from 2 Tower Place, South San Francisco, CA 94080, United States.

How many shares of LAB are traded daily?

LAB stock volume for the day was 102.58K shares. The average number of LAB shares traded daily for last 3 months was 2.2M.

What is the market cap of LAB currently?

The market value of LAB currently stands at $698.66M with its latest stock price at $1.88 and 371.15M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph